27.06.2011 • News

DSM Appoints New Chief Technology Officer

DSM has appointed Marcel Wubbolts, currently vice president R&D DSM Innovation Center, to the position of chief technology officer as of Oct.1, reporting to Rob van Leen, Chief Innovation Officer.

Marcel holds a PhD from the University of Groningen, NL, was post-doc and Assistent Professor at the ETH in Zürich. He joined DSM as a senior scientist and became Managing Director of DSM Biotech GmbH, in Jülich, Germany. Thereafter, he was competence manager Biocatalysis & Biotransformations and then became program director at the DSM Innovation Center in Delft, the Netherlands, running the Industrial (White) Biotechnology program

Marcel will succeed Jos Put who will continue to be an advisor to DSM e.g. in the field of material sciences and for several of the DSM Science and Technology awards.

 

Company

Royal DSM N.V.


6401 JH Heerlen

Company contact







Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

Driving Transformation
Interconnected Global Chemicals Logistics

Driving Transformation

DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.